Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
6.97
+0.04 (0.65%)
Nov 17, 2026, 2:34 PM EST - Market open

Envoy Medical Statistics

Total Valuation

Envoy Medical has a market cap or net worth of $53.94 million. The enterprise value is $40.15 million.

Market Cap53.94M
Enterprise Value 40.15M

Important Dates

The last earnings date was Thursday, November 5, 2026, before market open.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

Envoy Medical has 7.74 million shares outstanding. The number of shares has increased by 264.88% in one year.

Current Share Class 7.74M
Shares Outstanding 7.74M
Shares Change (YoY) +264.88%
Shares Change (QoQ) +0.29%
Owned by Insiders (%) 30.73%
Owned by Institutions (%) 13.00%
Float 4.34M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 231.33
Forward PS 138.80
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 171.62
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.21

Current Ratio 1.21
Quick Ratio 1.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -108.38%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -484.92%
Weighted Average Cost of Capital (WACC) 15.12%
Revenue Per Employee $4,915
Profits Per Employee -$552,128
Employee Count47
Asset Turnover 0.02
Inventory Turnover 0.54

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +4.28% in the last 52 weeks. The beta is 2.02, so Envoy Medical's price volatility has been higher than the market average.

Beta (5Y) 2.02
52-Week Price Change +4.28%
50-Day Moving Average 6.79
200-Day Moving Average 6.88
Relative Strength Index (RSI) 55.17
Average Volume (20 Days) 36,431

Short Selling Information

The latest short interest is 89,915, so 1.16% of the outstanding shares have been sold short.

Short Interest 89,915
Short Previous Month 577,087
Short % of Shares Out 1.16%
Short % of Float 2.07%
Short Ratio (days to cover) 4.48

Income Statement

In the last 12 months, Envoy Medical had revenue of $231,000 and -$25.95 million in losses. Loss per share was -$3.39.

Revenue231,000
Gross Profit -625,000
Operating Income -23.70M
Pretax Income -20.85M
Net Income -25.95M
EBITDA -23.40M
EBIT -23.70M
Loss Per Share -$3.39
Full Income Statement

Balance Sheet

The company has $14.57 million in cash and $777,000 in debt, with a net cash position of $13.79 million or $1.78 per share.

Cash & Cash Equivalents 14.57M
Total Debt 777,000
Net Cash 13.79M
Net Cash Per Share $1.78
Equity (Book Value) -1.14M
Book Value Per Share -0.15
Working Capital 2.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.23 million and capital expenditures -$205,000, giving a free cash flow of -$22.44 million.

Operating Cash Flow -22.23M
Capital Expenditures -205,000
Depreciation & Amortization 302,000
Net Borrowing -763,000
Free Cash Flow -22.44M
FCF Per Share -$2.90
Full Cash Flow Statement

Margins

Gross Margin -270.56%
Operating Margin -10,261.04%
Pretax Margin -9,026.41%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Envoy Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -264.88%
Shareholder Yield -264.88%
Earnings Yield -48.67%
FCF Yield -41.99%

Analyst Forecast

The average price target for Envoy Medical is $19.67, which is 182.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target $19.67
Price Target Difference 182.41%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (3Y) 231.13%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on October 26, 2026. It was a reverse split with a ratio of 1:10.

Last Split Date Oct 26, 2026
Split Type Reverse
Split Ratio 1:10

Scores

Envoy Medical has an Altman Z-Score of -26.88 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -26.88
Piotroski F-Score 3